Shan-Yue Tan

Peripheral blood markers predict prognosis in patients with advanced non-small cell lung cancer receiving immunotherapy

In recent years, immunotherapy has significantly reshaped the pattern of non-small cell lung cancer (NSCLC) treatment. However, the issue of how to pinpoint potential responsive populations more accurately warrants immediate and focused attention. This study mainly explored the correlation between baseline peripheral b...